Refine by
Alzheimer Disease Articles & Analysis
38 articles found
They support the maintenance of neuronal functions, promote repair processes following injury, and facilitate the recovery from neurodegenerative diseases. Role in Neurodegenerative Diseases Research has demonstrated that neurotrophic factors can be pivotal in the context of neurodegenerative diseases such as Alzheimer’s, ...
One notable study published in Nature Neuroscience (2021) demonstrated how CX3CL1-fractalkine signaling influences microglial activity in neurodegenerative diseases like Alzheimer’s. These findings suggest potential avenues for therapeutic intervention targeting neuroinflammation. ...
This approach is especially beneficial for investigating diseases with immune dysregulation, such as cancer, autoimmune disorders, or infectious diseases, where multiple cytokines orchestrate pathological processes. ...
This precision targeting is critical for treating diseases such as cancer, where minimizing damage to healthy tissues while aggressively targeting cancerous cells is paramount. ...
Targeted Drug Delivery Targeted drug delivery systems aim to deliver drugs specifically to diseased cells or tissues while minimizing exposure to healthy cells. PEG derivatives play a crucial role in developing such systems, particularly in oncology. ...
But when the time is right, it can hit the brakes on this growth, ensuring everything stays balanced and healthy. TNC Protein's Role in Disease Like many proteins, when TNC protein goes awry, disease can result. ...
Tau protein is a microtubule-associated protein, mainly present in nerve cells, and participates in the stabilization of microtubules. In certain neurodegenerative diseases, such as Alzheimer's disease (AD), Tau protein may undergo abnormal phosphorylation and aggregation, forming so-called Tau tangles or neurofibrillary tangles.Ubiquitination is ...
MMPs are involved in pathological processes such as hypertension, eclampsia, vascular inflammation, atherosclerosis, coronary syndromes and myocardial infarction, cerebral ischemia and ischemic stroke, peripheral arterial disease, aneurysms, chronic venous disease, etc. MMPs can be used as biomarkers and potential therapeutic targets for certain vascular ...
Imagine a world where diseases like cancer, Alzheimer's, and Parkinson's could be diagnosed and treated at the molecular level, long before symptoms even appear. ...
ByMatexcel
The field of medical science has long utilized disease models, which are systems simulating the progression and expression of a disease, to better understand various illnesses. ...
They contain a range of biomolecules, such as lipids, proteins, and nucleic acids. Cancer, Alzheimer's disease, and Parkinson's disease are just a few of the illnesses for which EVs can be used as biomarkers. ...
The field of medical science has long utilized disease models, which are systems simulating the progression and expression of a disease, to better understand various illnesses. ...
Drug-disease relationship analysis helps in unraveling these complexities by revealing the key players in disease progression. ...
Cholinesterase inhibitors play a crucial role in the treatment of Alzheimer's disease and other cognitive impairments by increasing the levels of acetylcholine in the brain, which is involved in memory and learning processes. ...
The findings could help develop new treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's, and help understand how to keep the brain healthy as we age. ...
Researchers are also developing TPD drugs to treat other types of diseases. Neurological diseases, including Alzheimer's disease (AD), are often considered "incurable" because conventional small molecules cannot interfere with the function of disease-associated proteins. ...
Application in medical research Etiology research. There are lots of untreated diseases with unknown etiologies, which are called idiopathic diseases in clinics. ...
To understand the significance of the SpinTech MRI STAGE software platform, it helps to begin by asking a question: Given that MRI is an incredibly powerful diagnostic tool for neurological diseases like Alzheimer’s, dementia, Parkinson’s and multiple sclerosis (MS), why have radiologists and neurologists had to choose between conducting faster MRI ...
People living with frontotemporal dementia, or FTD, are commonly misdiagnosed with psychiatric disorders or Alzheimer’s disease and other causes of dementia, such as Parkinson’s disease and vascular dementia. While frontotemporal dementia and Alzheimer’s disease can both cause dementia, there ...
These factors limit progress in developing new treatments for conditions like Alzheimer’s Disease, Parkinson’s Disease, Cancers, Autoimmune Disorders, and many others. ...